REGENERON PHARMACEUTIC

Dupixent® (dupilumab) Approved in China as the First-ever Biologic Medicine for Patients with Chronic Obstructive Pulmonary Disease (COPD)

27 سبتمبر 2024 06:00:04 بحسب Nasdaq GlobeNewswire

Regeneron to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on October 31, 2024

26 سبتمبر 2024 15:05:00 بحسب Nasdaq GlobeNewswire

Dupixent® (dupilumab) Recommended for EU Approval by the CHMP to Treat Eosinophilic Esophagitis (EoE) in Children as Young as 1 Year Old

20 سبتمبر 2024 06:45:00 بحسب Nasdaq GlobeNewswire

Dupixent® (dupilumab) Approved in the U.S. as First and Only Treatment for Adolescents with Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)

13 سبتمبر 2024 11:15:28 بحسب Nasdaq GlobeNewswire

EYLEA HD® (aflibercept) Injection 8 mg Data at EURETINA Reinforce Long-term Durability, Sustained Fluid Control and Safety Profile

11 سبتمبر 2024 06:00:46 بحسب Nasdaq GlobeNewswire

Dupixent® (dupilumab) Phase 3 Trial Confirms Significant Improvements in Itch and Hives for Patients with Chronic Spontaneous Urticaria (CSU)

11 سبتمبر 2024 00:04:00 بحسب Nasdaq GlobeNewswire

Dupixent® (dupilumab) Is the First and Only Biologic to Achieve Significant Improvements in Disease Remission and Symptoms in Bullous Pemphigoid (BP) Positive Pivotal Trial

10 سبتمبر 2024 23:59:00 بحسب Nasdaq GlobeNewswire

Libtayo® (cemiplimab) Demonstrates Durable Survival Benefit at Five Years in Advanced Non-small Cell Lung Cancer

09 سبتمبر 2024 16:00:00 بحسب Nasdaq GlobeNewswire

Regeneron to Highlight Progress Across Its Differentiated Oncology Portfolio and Pipeline at WCLC and ESMO

09 سبتمبر 2024 06:00:17 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

27 أغسطس 2024 09:44:05 بحسب NetDania Notify

NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

26 أغسطس 2024 12:12:44 بحسب NetDania Notify

Ordspono™ (odronextamab) Approved in the European Union for the Treatment of Relapsed/Refractory Follicular Lymphoma and Diffuse Large B-cell Lymphoma

26 أغسطس 2024 06:00:00 بحسب Nasdaq GlobeNewswire

Latest Dupixent® (dupilumab) and Itepekimab Data at ERS Highlight Scientific Innovation and Leadership in Respiratory Diseases

26 أغسطس 2024 00:00:00 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

21 أغسطس 2024 08:56:19 بحسب NetDania Notify

Regeneron Provides Update on Biologics License Application for Linvoseltamab

20 أغسطس 2024 17:45:05 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

20 أغسطس 2024 08:47:18 بحسب NetDania Notify

NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

19 أغسطس 2024 08:50:04 بحسب NetDania Notify

NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

16 أغسطس 2024 10:58:01 بحسب NetDania Notify

NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

15 أغسطس 2024 08:45:08 بحسب NetDania Notify

NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

14 أغسطس 2024 09:27:20 بحسب NetDania Notify